Company Overview of Okairos AG
Okairos AG, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of T-cell based vaccines for infectious diseases and cancer. It focuses on developing genetic vaccines for hepatitis C virus, malaria, HIV, respiratory syncytial virus, Ebola and Marburg, tuberculosis, and influenza, as well as cancer. The company was founded in 2007 and is headquartered in Basel, Switzerland. It has laboratories in Rome and Naples, Italy. As of May 29, 2013, Okairos AG operates as a subsidiary of GlaxoSmithKline plc.
Founded in 2007
41 61 270 35 35
41 61 270 35 00
Key Executives for Okairos AG
Similar Private Companies By Industry
|Vivendy Therapeutics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Okairos AG, please visit www.okairos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.